[{"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "4 units", "code_info": "Rx #'s:  0384580    0384580      0384580", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "THIAMINE HCL 100MG/ML INJECTABLE\t300 ML  \t360 ML  \t  \t450 ML  (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1625-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #'s:  0398994    0387653", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "OXYTOCIN 10UNITS/ML INJECTABLE\t25 ML;  OXYTOCIN**(25X1ML) 10U/ML INJECTABLE\t25 MLS  (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1590-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "8 units", "code_info": "Rx #'s:   0398900        0399056    0404399    0391716    0391716    0391716", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "METHYLPREDNISOLONE ACETATE 100MG/ML INJECTABLE\t50 ML;  \t  \t  \t  METHYLPREDNISOLONE ACETATE 80MG/ML INJECTABLE\t1 ML  \t30 ML  \t6 ML  \t60 ML  (5 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1575-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Hobart", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "61967", "recalling_firm": "Mallinckrodt Inc.", "address_1": "172 Railroad Avenue", "address_2": "N/A", "postal_code": "13788-0416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1430-2012", "product_description": "Hydrocodone Bitartrate and Acetaminophen Oral Solution, 7.5 mg/500 mg per 15 mL, 16 fl oz (473 mL) bottle, Rx only, Mallinckrodt Inc., Hazelwood, MO 63042 USA, NDC 0406-0375-16, UPC 3 0406-0375-16 1.", "product_quantity": "41,100 bottles", "reason_for_recall": "Subpotent (Multiple Ingredient) Drug: Low out of specification assay results for the hydrocodone bitartrate ingredient was found.", "recall_initiation_date": "20120525", "center_classification_date": "20120731", "termination_date": "20150417", "report_date": "20120808", "code_info": "Lot #: 0375T79384, Exp 05/13; 0375T81348,  Exp 09/13; 0375U82277, Exp 01/14"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "5 units", "code_info": "Rx #:  0370657    0391175    0397241      0397241", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DEXPANTHENOL 250MG/ML INJECTABLE 100 ML, 120 ML, 360 ML, 450 ML (4 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1499-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "9 units", "code_info": "Rx #'s:C0388707  C0393621  C0397891  C0397894  C0397896  C0397905  C0404812  C0405366  C0407575", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DEPO-TESTOSTERONE, MDV, 10ML** 200MG/ML INJECTABLE 10 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1496-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "11 units", "code_info": "Rx #'s:   0370173      0370173    0370173    0370173    0371532      0371532    0371532      0371532", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "LIDOCAINE/EPINEPHRINE/BUPIVACAINE, PF 1%/0.00025%/0.375% OPHTHALMIC\t30 ML  \t  \t48 ML  \t60 ML  \t90 ML;  LIDOCAINE/EPINEPHRINE/BUPIVACAINE, PF 1%/0.0005%/0.25% OPHTHALMIC\t30 ML  \t  \t48 ML  \t60 ML  \t  \t90 ML  (8 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1561-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "21 units", "code_info": "Rx #'s:   0392865    0396841    0392865    0389079      0401264    0401264    0389079    0351538    0379811    0398960        0396622    0367514", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CALCIUM CHLORIDE DIHYDRATE, P.F. 100MG/ML (10%) INJECTABLE 200 ML, 240 ML, 500 ML; CALCIUM EDTA 150MG/ML INJECTABLE 1000 ML, 800 ML, 900 ML; CALCIUM EDTA 300MG/ML INJECTABLE 400 ML, 500 ML; CALCIUM GLUCONATE OPHTHALMIC IN ARTIFICIAL TEARS 1%  OPHTHALMIC 500 ML (9 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1480-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "12 units", "code_info": "Rx #'s:  0387947    0391167      0394583    0394583      0394579    0390379          0390379", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HEPARIN LOCK SODIUM*** (25X1ML) 100U/ML INJECTABLE 50 ML;  HEPARIN LOCK SODIUM*** (25X5ML) 100U/ML INJECTABLE 125 MLS; HEPARIN SODIUM (25X30ML)** 1000U/ML(1MU/ML) INJECTABLE 120 ML, 60 ML, 90 ML; HEPARIN SODIUM **25X1ML 1000U/ML(1MU/ML INJECTABLE 25 ML, 50 ML (7 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1531-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Tulsa", "state": "OK", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "62924", "recalling_firm": "Physicians Total Care, Inc.", "address_1": "12515 E 55th St Ste 100", "address_2": "N/A", "postal_code": "74146-6234", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "FAX", "distribution_pattern": "VA", "recall_number": "D-090-2013", "product_description": "Enjuvia (synthetic conjugated estrogens, B) tablets, 0.3mg, 30-count tablets per bottle, Rx only, Mfg. By: Duramed Pharmaceuticals, Pomona NY 10970; Repacked & distributed by: Physicians Total Care, Inc., Tulsa, OK  74146; NDC 54868-6164-1.", "product_quantity": "5 bottles", "reason_for_recall": "Subpotent (Single ingredient) drug : This is a sub recall of Teva's Enjuvia due to low Out of Specification (OOS) assay results.", "recall_initiation_date": "20110408", "center_classification_date": "20121211", "termination_date": "20130222", "report_date": "20121219", "code_info": "62QJ, Exp 12/11"}, {"status": "Terminated", "city": "Toronto", "state": "N/A", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62574", "recalling_firm": "Apotex Inc.", "address_1": "150 Signet Drive", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1439-2012", "product_description": "Dorzolamide HCI/Timolol Maleate Ophthalmic Solution 22.3mg/6.8mg per mL, 10mL bottle, For Topical Application in the Eye, Sterile Ophthalmic Solution, Rx Only, Mfg by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9", "product_quantity": "119,794 Bottles", "reason_for_recall": "Presence of Particulate Matter:  Lots identified in this recall notification may contain small particulates.", "recall_initiation_date": "20120430", "center_classification_date": "20120802", "termination_date": "20130919", "report_date": "20120808", "code_info": "Lot #s: JN1060, JN1061, JN1062, Exp 06/12"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA072168"], "brand_name": ["CYTARABINE"], "generic_name": ["CYTARABINE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["61703-303"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CYTARABINE"], "rxcui": ["240416"], "spl_id": ["304df26a-131c-4ce1-999a-f13ade44373e"], "spl_set_id": ["681b5dc4-4fcf-4fab-ad78-02cb9a4a5dd0"], "package_ndc": ["61703-303-46"], "is_original_packager": [true], "nui": ["N0000000233", "N0000175595"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "unii": ["04079A1RDZ"]}, "product_type": "Drugs", "event_id": "62459", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, including Puerto Rico and Guam.    Product was also distributed internationally to Australia, Belgium, Canada, France, Germany, Korea, Malaysia, New Zealand, Norway, Pakistan, Philippines, Portugal, Singapore, Sweden, Thailand and  Vietnam", "recall_number": "D-1680-2012", "product_description": "Cytarabine Injection, 20 mg/mL, 50 mL Single Dose Vial, Rx only,  antineoplastic/cytotoxic agent; Manufactured for Hospira, Inc., Lake Forest, IL 60045, Product of Australia; NDC 61703-303-46", "product_quantity": "210 vials", "reason_for_recall": "The affected lots of Carboplatin Injection, Cytarabine  Injection, Methotrexate Injection, USP, and Paclitaxel Injection are being recalled due to visible particles embedded in the glass located at the neck of the vial. There may be the potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution.", "recall_initiation_date": "20120627", "center_classification_date": "20120919", "termination_date": "20161215", "report_date": "20120926", "code_info": "lot numbers Y131994AA, exp AUG 2013; Y141994AA, exp SEP 2013; Y151994AA, exp SEP 2013; Y161994AA, exp NOV 2013; Y171994AA, exp NOV 2013 and Y181994AA, exp NOV 2013", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:  0389781", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HUMULIN-R INSULIN, 10ML VIAL** 100U/ML INJECTABLE\t10 MLS (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1532-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "107 units", "code_info": "Rx #'s:   0368127    0368127        0396422    0394589    0389031    0397908    0405717    0377092    0395743    0399094    0364766    0377092    0383467    0395743    0399094    0385418    0377092    0391512    0397919    0409221    0395743      0383467    0410209    0353611    0397908    0409800    0372333    0381650    0388770    0357605    0399192    0357605    0357605    0399192        0357605    0370950    0384873    0389326    0357967    0399100      0356533    0361811    0368706    0392087    0401999    0402000    0402006    0405708    0408219    0361811    0368706      0371146    0379509    0380104    0384873          0393576    0403473    0405271    0405527    0371848      0388317    0399025    0408772    0398966      0398276    0352407    0371146      0375451      0377804        0383961    0384873      0388317    0391725    0392087      0393569    0396968    0371146      0375451    0368706    0399665    0401355    0402666      0407936    0362282    0388317      0368311", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DMSO / BUPIVACAINE HCL 50%/0.5% INJECTABLE 100 ML, 50 ML; DMSO 100% INJECTABLE 100 ML; DMSO FORTIFIED IRRIGATION - W/O HEPARIN  SOLUTION\t350 ML; DMSO FORTIFIED IRRIGATION 50%/0.01%/44%/1% SOLUTION\t1000 ML, 1200 ML, 150 ML, 200 ML, 250 ML, 300 ML, 400 ML, 500 ML, 600 ML; DMSO FORTIFIED IRRIGATION 50%/44%/1% SOLUTION\t50 ML;  DMSO FORTIFIED IRRIGATION W/LIDOCAINE 50%/0.01%/44%/1%/1% SOLUTION\t250 ML; DMSO IRRIGATION - NACHO3 50% SOLUTION 100 ML, 300 ML, 400 ML, 500 ML, 600 ML; DMSO W/LIDOCAINE 50%/0.5% SOLUTION 100 ML, 1200 ML, 150 ML, 200 ML,\t250 ML, 2500 ML, 30 ML, 300 ML, 400 ML, 50 ML, 500 ML, 600 ML (32 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1505-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62511", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distribution was nationwide, including Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-076-2013", "product_description": "Thyro-Tab 0.088 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "3,826,269 tablets", "reason_for_recall": "cGMP Deviations; does not meet in process specification requirements", "recall_initiation_date": "20120709", "center_classification_date": "20121203", "termination_date": "20131114", "report_date": "20121212", "code_info": "Lot #HA31411 and #HE17811"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "193 units", "code_info": "Rx #'s:  0389332    0388230      0362007    0362537    0369266    0369759    0376765      0376766    0378972    0381347    0381668    0383006    0384070    0387408    0387842    0387873    0388522    0388825    0389034    0389038    0389347    0389746    0389824    0389913    0390210    0390265    0390267    0390404    0390481    0391083    0391374    0391789    0392302    0392329    0393161    0393238    0393733    0393734    0394038    0396204    0396253    0396951    0397068    0397814    0397816    0398167    0398775    0398809    0399039      0399168      0400419      0401454    0401456    0401717    0402440    0402443    0403637    0377693    0382907    0389892    0390269    0393418    0397085    0397984    0398761    0401192    0401453    0401702    0402969    0403042    0353856    0380968        0389852    0396383    0396985      0397369    0405720    0409461    0400111    0392017    0405577    0405591    0407190    0390553            0410265    0393727    0394656    0399169    0403590      0392209    0392212    0392214    0392215    0392217    0394902    0395795    0395799    0395800    0395880      0395884      0395885      0398821    0399797    0403933    0405574    0405578    0405607    0405608    0406394    0410495    0394528    0395347    0392045    0393681    0393682    0394381    0396742    0396763    0401783    0401785    0405205    0404805    0397298      0398209    0401610    0404696    0406424    0408386    0408794    0409008    0409330    0409500    0409511    0410093    0410179    0410202    0410327    0394569    0397231    0400352    0400360    0410043    0410045    0410046    0394569    0394569    0407106    0407854    0409176    0408788    0394569      0405634    0394765    0405634    0392318    0394569    0373437    0381856    0387413    0397985    0398350    0394512    0401471    0404558    0393614    0397800    0387413    0406999    0397800    0397822    0388830      0380110    0407385    0380110", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CHORIONIC GONADOTROPIN (STANDARD) - 21 DAY 200 UNIT VIALS KIT 1 KIT; CHORIONIC GONADOTROPIN (STANDARD) - 45 DAY 200 UNIT VIALS KIT 1 KIT; CHORIONIC GONADOTROPIN (STANDARD)-21 DAY 125 UNIT VIALS KIT 1 KIT; CHORIONIC GONADOTROPIN (STANDARD)-45 DAY 125 UNIT VIALS KIT 1 KIT; CHORIONIC GONADOTROPIN + B12, LYOPHILIZED  4,000 UNIT/40MCG/ML KIT 1 KIT, 2 KIT, 3 KIT; CHORIONIC GONADOTROPIN + B12, LYOPHILIZED (HCG) 4,000 UNIT VIAL INJECTABLE 1 VIAL, 12 VIALS;  CHORIONIC GONADOTROPIN KIT 5,000 UNIT VIAL INJECTABLE 1 KIT; CHORIONIC GONADOTROPIN** KIT 10,000 UNIT VIAL INJECTABLE 1 KIT; CHORIONIC GONADOTROPIN, HUMAN - MINI 250 UNITS TROCHE 30 TROCHE, 45 TROCHE, 50 TROCHE, 60 TROCHE, 80 TROCHE; CHORIONIC GONADOTROPIN, LYOPHILIZED   (HCG) 1,000 UNIT VIAL INJECTABLE 30 VIAL; CHORIONIC GONADOTROPIN, LYOPHILIZED   (HCG) 5,000 UNIT VIAL INJECTABLE 1 VIAL, 10 VIAL, 14 VIAL, 15 VIAL, 2 VIAL, 2 VIALS, 20 VIAL, 3 VIAL, 5 VIAL, 6 VIAL; CHORIONIC GONADOTROPIN, LYOPHILIZED  (HCG) 125 UNIT VIAL (UNIT DOSE) INJECTABLE 10 VIAL, 14 VIAL, 15 VIAL,\t2 VIAL, 24 VIAL, 28 VIAL, 28 VIALS, 7 VIAL,\t7 VIALS; CHORIONIC GONADOTROPIN, LYOPHILIZED (HCG) 2,500 UNIT VIAL INJECTABLE 5 VIAL; CHORIONIC GONADOTROPIN, LYOPHILIZED (HCG) 200 UNIT VIAL (UNIT DOSE) INJECTABLE 22 VIAL, 25 VIAL, 8 VIAL (40 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1483-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA088325"], "brand_name": ["LIDOCAINE HYDROCHLORIDE"], "generic_name": ["LIDOCAINE HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-4275", "0409-4713", "0409-4278", "0409-4279", "0409-4776", "0409-4282", "0409-4277", "0409-4276"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INFILTRATION", "PERINEURAL"], "substance_name": ["LIDOCAINE HYDROCHLORIDE"], "rxcui": ["1010033", "1010671", "1010900", "1737343", "1737562", "1737566", "1737568", "1737636", "1737757", "1737763"], "spl_id": ["d0322a93-069a-453f-89eb-e5d5559ed075"], "spl_set_id": ["3b2dd84e-cee8-4e58-d494-395a65a353a0"], "package_ndc": ["0409-4713-12", "0409-4713-26", "0409-4713-02", "0409-4713-72", "0409-4713-62", "0409-4713-75", "0409-4713-65", "0409-4713-42", "0409-4713-25", "0409-4713-32", "0409-4278-16", "0409-4278-01", "0409-4279-16", "0409-4279-02", "0409-4776-10", "0409-4776-01", "0409-4282-11", "0409-4282-25", "0409-4282-01", "0409-4282-12", "0409-4282-02", "0409-4277-16", "0409-4277-01", "0409-4277-17", "0409-4277-02", "0409-4276-16", "0409-4276-01", "0409-4276-17", "0409-4276-02", "0409-4275-16", "0409-4275-01"], "is_original_packager": [true], "unii": ["V13007Z41A"]}, "product_type": "Drugs", "event_id": "63913", "recalling_firm": "Hospira, Inc.", "address_1": "600 N Field Dr Bldg J45", "address_2": "", "postal_code": "60045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-099-2013", "product_description": "Lidocaine HCl Injection, USP, 1% (10 mg/mL), 30 mL Single-dose Teartop Vial, packaged in 25-count vials per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045; NDC 0409-4279-02.", "product_quantity": "120,350 vials", "reason_for_recall": "Presence of Particulate Matter: Report of a vial containing visible particulate matter embedded in the glass wall which has the potential to dislodge resulting in the presence of particulate matter in the product.", "recall_initiation_date": "20121004", "center_classification_date": "20121220", "termination_date": "20140508", "report_date": "20121226", "code_info": "Lot #: 14-277-DK*, Exp 02/01/14; * may be followed by 01", "more_code_info": ""}, {"country": "United States", "city": "Westborough", "address_1": "201 Flanders Rd", "reason_for_recall": "Lack of assurance of sterility", "address_2": "", "product_quantity": "", "code_info": "All lot codes within expiry", "center_classification_date": "20121114", "distribution_pattern": "Nationwide", "state": "MA", "product_description": "All Sterile Products manufactured by Ameridose LLC, Westborough, MA.  A complete list of all products subject to this recall can be accessed on-line at www.ameridose.com", "report_date": "20121121", "classification": "Class II", "openfda": {}, "recalling_firm": "Ameridose LLC", "recall_number": "D-054-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "63585", "termination_date": "20160725", "more_code_info": "", "recall_initiation_date": "20121031", "postal_code": "01581-1032", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "63488", "recalling_firm": "Valeant Pharmaceuticals", "address_1": "700 Rte 206 North", "address_2": "N/A", "postal_code": "08807", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-047-2013", "product_description": "AcneFree 3-in-1 Acne Night Repair Foam (retinol + salicylic acid 1.5% w/v), 3 oz (85 g) canister, Dist. by: University Medical Pharmaceuticals Corp., Irvine, CA  92618, UPC 7 88521 13548 6.", "product_quantity": "81,319 canisters", "reason_for_recall": "Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the salicylic acid ingredient.  Additionally, this product is mislabeled because the label either omits or erroneously added inactive ingredients to the label.", "recall_initiation_date": "20121015", "center_classification_date": "20121106", "termination_date": "20130325", "report_date": "20121114", "code_info": "All lots with expiration dates between 10/10/12 through 10/10/14 of UPC 7 88521 13548 6"}, {"country": "United States", "city": "Broomfield", "address_1": "2555 W Midway Blvd", "reason_for_recall": "Impurities/Degradation Products: An out of specification result for a known impurity of the product occurred during 12 month stability testing.", "address_2": "", "product_quantity": "43,060 x 90 count bottles", "code_info": "Lot numbers: BJ3338; BJ3339; BJ 3340; BJ3341; BJ3342; BJ6282; BJ7192; BM8498; BJ7202; BJ7203, Exp 12/12", "center_classification_date": "20120919", "distribution_pattern": "Nationwide", "state": "CO", "product_description": "Pramipexole Dihydrochloride Tablets, 0.25 mg, 90-count tablets per bottle, Rx only, Manufactured in India by Sandoz Private Ltd., for Sandoz Inc., Princeton, NJ 08540, NDC 0781-  5249-92,", "report_date": "20120926", "classification": "Class III", "openfda": {}, "recalling_firm": "Sandoz Incorporated", "recall_number": "D-1677-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "63160", "termination_date": "20130410", "more_code_info": "", "recall_initiation_date": "20120912", "postal_code": "80020-1632", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Morristown", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M027"], "brand_name": ["MIDOL COMPLETE"], "generic_name": ["ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE"], "manufacturer_name": ["Bayer HealthCare LLC."], "product_ndc": ["0280-8005"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN", "CAFFEINE", "PYRILAMINE MALEATE"], "rxcui": ["1597298"], "spl_id": ["32714ca6-82e9-932c-e063-6394a90ae97d"], "spl_set_id": ["ce9e6acb-a38b-4c9b-a7e8-3e1c2a49a324"], "package_ndc": ["0280-8005-16", "0280-8005-24", "0280-8005-40", "0280-8005-01", "0280-8005-02", "0280-8005-04", "0280-8005-25"], "is_original_packager": [true], "upc": ["0312843555198"], "nui": ["N0000175739", "N0000175729", "N0000175790", "M0023046"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "pharm_class_cs": ["Xanthines [CS]"], "unii": ["362O9ITL9D", "3G6A5W338E", "R35D29L3ZA"]}, "product_type": "Drugs", "event_id": "61948", "recalling_firm": "Bayer Healthcare, LLC", "address_1": "36 Columbia Rd", "address_2": "", "postal_code": "07960-4526", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 93 retail accounts/customers.", "recall_number": "D-1424-2012", "product_description": "Midol Complete, Acetaminophen, Caffeine, Pyrilamine Maleate, Caplets, OTC, a) 16 ct. blister (NDC 0280-8005-16), b)24 ct. blister, Distributed by Bayer Health Care, Morristown, NJ 07962 (NDC 0280-8005-25)", "product_quantity": "48,528 cartons", "reason_for_recall": "Labeling: Label Mix-up: This recall was initiated after identifying that the label statement on the blister strip regarding the maximum number of capsules/caplets that should be taken within a 24-hour period, does not match the statement on the carton.", "recall_initiation_date": "20120426", "center_classification_date": "20120719", "termination_date": "20140327", "report_date": "20120725", "code_info": "NAA055N Exp.12/13, NAA05PC Exp.12/13, NAA0462 Exp.12/13", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "10 units", "code_info": "Rx #'s: 0390522, 0390522, 0353081, 0390522, 0390522, 0398989", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "ACETAZOLAMIDE, LYOPHILIZED 500MG INJECTABLE10 VIAL, 4 VIAL, 5 VIAL, 6 VIAL, 8 VIAL (5 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1447-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #:  0398930", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "FOLIC ACID 10MG/ML INJECTABLE 60 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1521-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078765"], "brand_name": ["FOSPHENYTOIN SODIUM"], "generic_name": ["FOSPHENYTOIN SODIUM"], "manufacturer_name": ["West-Ward Pharmaceuticals Corp"], "product_ndc": ["0143-9782", "0143-9788"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["FOSPHENYTOIN SODIUM"], "rxcui": ["1670195", "1670200"], "spl_id": ["6b56fe59-9fb1-410b-b57c-7ada1662136a"], "spl_set_id": ["c92df63b-5140-4213-8d43-8327ff6230b7"], "package_ndc": ["0143-9788-01", "0143-9788-25", "0143-9782-01", "0143-9782-10", "0143-9704-25"], "is_original_packager": [true], "unii": ["7VLR55452Z"]}, "product_type": "Drugs", "event_id": "62627", "recalling_firm": "West-ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "All lots were distributed throughout the US.", "recall_number": "D-1437-2012", "product_description": "Fosphenytoin Sodium Injection, USP, 100 mg PE per 2 mL (50 mg PE per mL), 2 mL Single Dose Vial, packaged in 25-count x 2 mL Single Dose Vials per carton, Rx only, Mfd. By: Hikma Farmaceutica (Portugal), S.A.; Dist. By: West-Ward Pharmaceutical Corp., Eatontown, NJ  07724 USA under the labels a) NOVAPLUS (NDC 0143-9704-25), b) West-Ward (NDC 0143-9788-25).", "product_quantity": "a) 308,275 vials; b) 2,008,850 vials", "reason_for_recall": "Presence of Particulate Matter: This product is being recalled due to the discovery of particles in the stability samples and retain samples.", "recall_initiation_date": "20120413", "center_classification_date": "20120802", "termination_date": "20150116", "report_date": "20120808", "code_info": "Lot #s: a) 113153.1, 113154.1, 113155.1, Exp 05/13; 113248.1, Exp 07/13; b) 103196.1, 103197.1, 103197.2, 103198.1, Exp 07/12; 103317.1, 103318.1, 103319.1, 103345.1, 103345.2, Exp 11/12; 103346.1, 103347.1, 103348.1, 103349.1, 103350.1, Exp 12/12; 113030.1, 113031.1, 113032.1, 113033.1, 113034.1, 113035.1, 113036.1, Exp 01/13; 113245.1, 113246.1, 113247.1, Exp 07/13"}, {"status": "Terminated", "city": "Round Lake", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63189", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "Route 120 And Wilson Rd", "address_2": "N/A", "postal_code": "60073-9799", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1689-2012", "product_description": "0.9% Sodium Chloride Injection USP, packaged in a) 250 mL AVIVA Container, product code 6E1322, NDC 0338-6304-02; b) 500 mL AVIVA Container, product code 6E1323,  NDC 0338-6304-03; Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA", "product_quantity": "897,496 containers", "reason_for_recall": "Chemical Contamination: The IV solutions were packaged in AVIVA containers which may contain trace levels of cumene hydroperoxide (CHP).", "recall_initiation_date": "20120921", "center_classification_date": "20120925", "termination_date": "20150504", "report_date": "20121003", "code_info": "Lot #: a) C840892, C841007, C841403, Exp 09/12; C842377, C842757, C843748, C843946, Exp 10/12; C844332, C845065, C845198, C845347, C846873, C847301, C847608, Exp 11/12; C848481, C848937, C849554, C850180, Exp 12/12; C850966, C851097, C851212, C852459, C853044, C853614, Exp 01/13; C853747, C854455, C854711, C854836, C854943, C856013, C856138, Exp 02/13; C856948, C858027, Exp 03/13; C858712, C859066, C859199, C859389, C860569, C861021, Exp 04/13; C861856, C862953, C863076, C863183, Exp 05/13; C865188, C865824, C866178, C866178A, Exp 06/13; C867168, C868117, C868570, C868703, Exp 07/13;  b) C818187, C819367, Exp 09/12; C821686, Exp 10/12; C823377, Exp 11/12; C826255, C828111, C828228, Exp 12/12; C830455, C830604, Exp 01/13; C832964, C833152, Exp 02/13; C839134, C840587, Exp 04/13; C842740, C843649, Exp 05/13; C844647, C845941, C847038, Exp 06/13; C848184, C849117, C850545, Exp 07/13; C850842, C851568, C852806, Exp 08/13; C853853, C854216, C854216A, C855213, Exp 09/13; C856567, C858142, C858258, Exp 10/13; C858613, C859777, C859777A, C860916, Exp 11/13; C861617, C861724, Exp 12/13; C865311, C866285, Exp 01/14; C866632, C866830, Exp 02/14", "more_code_info": ""}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076919"], "brand_name": ["LEVETIRACETAM"], "generic_name": ["LEVETIRACETAM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-5615", "0378-5617", "0378-5619"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVETIRACETAM"], "rxcui": ["311289", "311290", "387003"], "spl_id": ["8eaa3318-fe96-4d3e-9f49-3286cb04bfbf"], "spl_set_id": ["0a987d59-560f-4650-96ec-31aec81953b5"], "package_ndc": ["0378-5615-78", "0378-5615-05", "0378-5617-78", "0378-5617-05", "0378-5619-91"], "is_original_packager": [true], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["44YRR34555"]}, "product_type": "Drugs", "event_id": "62885", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The product was distributed to KY.", "recall_number": "D-1702-2012", "product_description": "Levetiracetam Tablets, USP 500 mg, 500 count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 USA, NDC 0378-5615-05", "product_quantity": "960 bottles", "reason_for_recall": "Adulterated Presence of Foreign Tablets: Pharmaceutical manufacturer may have distributed foreign tablets in bottles of Levetiracetam Tablets, USP 500 mg.", "recall_initiation_date": "20120727", "center_classification_date": "20120927", "termination_date": "20130521", "report_date": "20121003", "code_info": "Lot ZLMM12063, Exp March 2014", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "4 units", "code_info": "Rx #'s:  0408599    0401410    0402367", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "METHYLPREDNISOLONE ACETATE/LIDOCAINE HCL 40MG/10MG/ML INJECTABLE\t100 ML  \t500 ML;  METHYLPREDNISOLONE/LIDOCAINE 80MG/10MG/ML INJECTABLE\t24 ML  (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1576-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Shirley", "address_1": "One Luitpold Drive", "reason_for_recall": "Presence of Particulate Matter", "address_2": "P.O. Box 9001", "product_quantity": "63,750 ampules", "code_info": "Lot #1395 Exp: July 2012", "center_classification_date": "20120716", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "Epinephrine Injection, USP, 1:1000 (1 mg/mL), 25 x 1 mL Ampules, For SC and IM Use, For IV and IC Use after Dilution,  Rx Only, American Regent, Inc., Shirely, NY 11967 --NDC 0517-1071-25", "report_date": "20120725", "classification": "Class II", "openfda": {}, "recalling_firm": "Luitpold Pharmaceuticals, Inc.", "recall_number": "D-1421-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "61714", "termination_date": "20170411", "more_code_info": "", "recall_initiation_date": "20120424", "postal_code": "11967-9001", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "63538", "recalling_firm": "Ferring Pharmaceuticals Inc", "address_1": "4 Gatehall Dr Fl 3rd", "address_2": "N/A", "postal_code": "07054-4518", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "nationwide", "recall_number": "D-073-2013", "product_description": "Novarel\u00bf (Chorionic Gonadotropin for injection, USP), 10,000 USP FOR INTRAMUSCULAR USE ONLY Rx Only NDC 55566-1501-0    Manufactured for : Ferring Pharmaceuticals Inc., Parsippany, NJ   07054    Manufactured by: DRAXIS Specialty Pharmaceuticals Inc., Quebec, Canada.       NDC # 55566-1501-0 is assigned to the vial of NOVAREL and is displayed on the vial label.  NDC # 55566-1501-1 is assigned to the unit of sale, which is a carton containing 1 vial of NOVAREL and 1 vial of diluent along with the insert.  NDC # 55566-1501-1 is displayed on the unit of sale and is the item subject to recall.", "product_quantity": "146,867 Vials", "reason_for_recall": "Labeling; incorrect or missing insert; Warnings portion of the Package Insert is missing the warning statement: Anaphylaxis has been reported with urinary-derived hCG products.", "recall_initiation_date": "20120823", "center_classification_date": "20121130", "termination_date": "20140530", "report_date": "20121212", "code_info": "Lot Number Expiration Date  1C264A 09/12  1H047A 12/12  1H047B 12/12  1H052A 12/12  1H052B 04/13  1H052C 04/13  1M417A 04/13  1M417B 09/13  2A012A 09/13  2A012B 11/13  2C278A 09/13  2C278B 09/13  2C278C 11/13  2C278D 11/13  2C278E 11/13"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077908"], "brand_name": ["PROPOFOL"], "generic_name": ["PROPOFOL"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-4699", "0409-6010"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PROPOFOL"], "rxcui": ["1808217", "1808222", "1808224"], "spl_id": ["d55c0318-811d-4624-aa0c-456182f7b019"], "spl_set_id": ["28d7ba00-f824-4e55-139a-03f509c099db"], "package_ndc": ["0409-4699-50", "0409-4699-30", "0409-4699-53", "0409-4699-33", "0409-4699-54", "0409-4699-24", "0409-6010-02", "0409-6010-25"], "is_original_packager": [true], "nui": ["N0000175975", "N0000175681"], "pharm_class_pe": ["General Anesthesia [PE]"], "pharm_class_epc": ["General Anesthetic [EPC]"], "unii": ["YI7VU623SF"]}, "product_type": "Drugs", "event_id": "63198", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1685-2012", "product_description": "Propofol Injectable Emulsion, 1%, packaged in a) 20 mL Single patient infusion vial, 200 mg/20 mL (10 mg/mL), NDC 0409-4699-30; b) 50 mL Single patient infusion vial, 500 mg/50 mL (10 mg/mL), NDC 0409-4699-33; c) 100 mL Single patient infusion vial, 1 g/100 mL (10 mg/mL), NDC 0409-4699-24; Rx only, Hospira, Inc., Lake Forest, IL 60045 USA", "product_quantity": "148,630 vials", "reason_for_recall": "Presence of Particulate Matter: A single visible particulate was observed and confirmed in sample bottles of the recalled lots during retain inspection.", "recall_initiation_date": "20120829", "center_classification_date": "20120921", "termination_date": "20130808", "report_date": "20121003", "code_info": "Lot No: a) 93-857-DJ, 93-896-DJ, Exp 1SEP2012; 04-515-DJ, Exp 1APR2013; 06-802-DJ, Exp 1JUN2013; b) 01-175-DJ, Exp 1JAN2013; 04-565-DJ, Exp 1APR2013; c) 03-388-DJ, Exp 1MAR2013; The lot number may be followed by 01 or 02", "more_code_info": ""}, {"status": "Terminated", "city": "Bedford", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "62422", "recalling_firm": "Ben Venue Laboratories Inc", "address_1": "300 Northfield Rd", "address_2": "N/A", "postal_code": "44146", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-1697-2012", "product_description": "Vecuronium Bromide for Injection, For IV use only, 20 mg per vial, 10 x 10 mg Vials, lyophilized powder per carton, Rx Only, Mfr. By: Ben Venue Laboratories, Bedford, OH 44146: Mfg for: Bedford Labs, Bedford, OH 44146, NDC 55390-039-10.", "product_quantity": "797 boxes/10/20 mg vials", "reason_for_recall": "Presence of Particulate Matter", "recall_initiation_date": "20120626", "center_classification_date": "20120926", "termination_date": "20140203", "report_date": "20121003", "code_info": "Lot #2067134 Exp 5/31/2013, NDC 55390-039-10", "more_code_info": ""}, {"status": "Terminated", "city": "Buffalo Grove", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA076639"], "brand_name": ["CIPROFLOXACIN"], "generic_name": ["CIPROFLOXACIN"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["16571-411", "16571-412", "16571-413"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CIPROFLOXACIN HYDROCHLORIDE"], "rxcui": ["197511", "197512", "309309"], "spl_id": ["f031ce92-a4ed-45b0-8eb3-c3bdb02fbece"], "spl_set_id": ["ef468722-68cd-440b-afd7-2285029db41f"], "package_ndc": ["16571-411-10", "16571-412-10", "16571-412-50", "16571-413-05"], "is_original_packager": [true], "upc": ["0316577411102", "0316571412501"], "unii": ["4BA73M5E37"]}, "product_type": "Drugs", "event_id": "51880", "recalling_firm": "Pack Pharmaceuticals", "address_1": "1110 W Lake Cook Rd", "address_2": "Ste 301", "postal_code": "60089-1944", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1422-2012", "product_description": "Ciprofloxacin Tablets, USP, 500 mg, Rx Only, 100 Tablets per Bottle, Manufactured in India by: Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai - 400 030, Distributed by: PACK Pharmaceuticals, LLC, Buffalo Grove, IL 60089, NDC 16571-412-10.", "product_quantity": "4,848 bottles", "reason_for_recall": "Labeling Illegible: Missing Label; The voluntary recall of the aforementioned batch of product is being initiated due to two bottles missing container labels.", "recall_initiation_date": "20120309", "center_classification_date": "20120719", "termination_date": "20120719", "report_date": "20120725", "code_info": "Lot #: : PUB1040, Exp 08/2015", "more_code_info": ""}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "62383", "recalling_firm": "Watson Laboratories Inc", "address_1": "311 Bonnie Cir", "address_2": "N/A", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1403-2012", "product_description": "Loxitane Capsules, Loxapine Succinate Capsules,  10mg base, 100 count bottle, Rx only,   Watson Laboratories Inc., Corona, CA 92880 NDC #  52544-495-01", "product_quantity": "7,262 bottles", "reason_for_recall": "Labeling: Incorrect or Missing Package Insert:  An outdated version of a patient outsert was used when packaged.", "recall_initiation_date": "20120417", "center_classification_date": "20120629", "termination_date": "20130318", "report_date": "20120711", "code_info": "Lot # 22478A"}, {"status": "Terminated", "city": "Sellersville", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020622"], "brand_name": ["COPAXONE"], "generic_name": ["GLATIRAMER ACETATE"], "manufacturer_name": ["Teva Neuroscience, Inc."], "product_ndc": ["68546-317", "68546-325"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["GLATIRAMER ACETATE"], "rxcui": ["1111641", "1111642", "1487361", "1487363"], "spl_id": ["5a691b1f-367f-4635-a7d6-0111361a2dbb"], "spl_set_id": ["aa88f583-4f5f-433b-80b4-1f4c9fb28357"], "package_ndc": ["68546-317-00", "68546-317-30", "68546-325-06", "68546-325-12"], "is_original_packager": [true], "unii": ["5M691HL4BO"]}, "product_type": "Drugs", "event_id": "62241", "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "address_1": "650 Cathill Rd", "address_2": "", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1442-2012", "product_description": "Copaxone (glatiramer acetate injection),  20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30", "product_quantity": "6,647 cartons", "reason_for_recall": "Presence of Foreign Substance: Recall is being initiated due to the presence of a foreign particle identified from a customer complaint.", "recall_initiation_date": "20120518", "center_classification_date": "20120803", "termination_date": "20130411", "report_date": "20120815", "code_info": "Lot number X05011, Exp 08/13", "more_code_info": ""}]